Literature DB >> 11085828

Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification.

M J Shearer1.   

Abstract

Among the proteins known or suspected to be involved in bone and vascular biology are several members of the vitamin K-dependent or Gla protein family. This review focuses on the role of two of these: osteocalcin and matrix Gla protein. Osteocalcin metabolism has been implicated in the pathogenesis of osteoporosis through an unknown mechanism that may be linked to suboptimal vitamin K status resulting in its undercarboxylation and presumed dysfunction. Recent studies that have investigated this hypothesis are discussed, as are recent promising clinical studies of vitamin K supplementation in osteoporosis. A recently delineated function of matrix Gla protein is as a powerful inhibitor of calcification of arteries and cartilage. In the period covered by this review there have been several landmark studies using cell systems, whole animals and genetic techniques that have consolidated and extended our knowledge of the role of matrix Gla protein in the prevention of ectopic calcification.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085828     DOI: 10.1097/00075197-200011000-00004

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  32 in total

Review 1.  The skeletal subsystem as an integrative physiology paradigm.

Authors:  Aaron J Weiss; Jameel Iqbal; Neeha Zaidi; Jeffrey I Mechanick
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

2.  Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene.

Authors:  Qiaoli Li; Leon J Schurgers; Ann C M Smith; Maria Tsokos; Jouni Uitto; Edward W Cowen
Journal:  Am J Pathol       Date:  2008-12-30       Impact factor: 4.307

3.  Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes.

Authors:  Qiaoli Li; Dorothy K Grange; Nicole L Armstrong; Alison J Whelan; Maria Y Hurley; Mark A Rishavy; Kevin W Hallgren; Kathleen L Berkner; Leon J Schurgers; Qiujie Jiang; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2008-09-18       Impact factor: 8.551

4.  Effects of vitamin K intake on gamma-carboxylated proteins, bone fractures, and vascular calcifications.

Authors:  M Fusaro; G Crepaldi; D Miozzo; L Gravellone; M Gallieni
Journal:  Osteoporos Int       Date:  2011-06-17       Impact factor: 4.507

5.  Modifier genes in pseudoxanthoma elasticum: novel insights from the Ggcx mouse model.

Authors:  Alain Hovnanian
Journal:  J Mol Med (Berl)       Date:  2010-02-11       Impact factor: 4.599

6.  Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice-potential for treatment of pseudoxanthoma elasticum.

Authors:  Qiaoli Li; Jennifer Larusso; Alix E Grand-Pierre; Jouni Uitto
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

Review 7.  Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.

Authors:  Qiaoli Li; Qiujie Jiang; Ellen Pfendner; András Váradi; Jouni Uitto
Journal:  Exp Dermatol       Date:  2008-10-22       Impact factor: 3.960

8.  Detecting species-site dependencies in large multiple sequence alignments.

Authors:  Roland Schwarz; Philipp N Seibel; Sven Rahmann; Christoph Schoen; Mirja Huenerberg; Clemens Müller-Reible; Thomas Dandekar; Rachel Karchin; Jörg Schultz; Tobias Müller
Journal:  Nucleic Acids Res       Date:  2009-08-06       Impact factor: 16.971

9.  A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats.

Authors:  Michael H Kohn; Roger E Price; Hans-Joachim Pelz
Journal:  Artery Res       Date:  2008-11       Impact factor: 0.597

10.  Chemical substructures that enrich for biological activity.

Authors:  Justin Klekota; Frederick P Roth
Journal:  Bioinformatics       Date:  2008-09-10       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.